Stock listing

XLO Stock Price, News, Filings & Events — Xilio Therapeutics, Inc.

Selected listing: XLO · NASDAQ · USD · US

This page tracks Xilio Therapeutics, Inc.'s XLO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following XLO:NASDAQ. XLO:NASDAQ is the stock-level entry point for investors researching Xilio Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Xilio Therapeutics, Inc. is a public company traded under the ticker XLO in the American market. The company has a market capitalization of approximately $58.4 million. Xilio focuses on developing innovative therapies to improve patient outcomes in cancer treatment.

XLO:NASDAQUSDUSUpdated September 4, 2026
Xilio Therapeutics, Inc. logo
Ticker
XLO:NASDAQ
Asset type
Stock
Market cap
$59.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Xilio Therapeutics, Inc. XLO:NASDAQ stock context

This page tracks Xilio Therapeutics, Inc.'s XLO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following XLO:NASDAQ. XLO:NASDAQ is the stock-level entry point for investors researching Xilio Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Xilio Therapeutics, Inc. is a public company traded under the ticker XLO in the American market. The company has a market capitalization of approximately $58.4 million. Xilio focuses on developing innovative therapies to improve patient outcomes in cancer treatment.

Latest news from Xilio Therapeutics, Inc.

All Xilio Therapeutics, Inc. news →

Research Xilio Therapeutics, Inc.

Alternate listings